Key result
Interferon epsilon is a unique type I interferon constitutively expressed in mucosal tissues that plays a crucial role in mucosal immunity and exhibits antiviral activity against pathogens like HIV.
This review summarizes the known antiviral and immunomodulatory activities of interferon epsilon, highlighting its potential role in mucosal immunity and future treatments.
Answers are grounded in this paper and cite their sources.
May guide mucosal antiviral strategies in HIV; leaves open clinical translation pending interventional trials.
Interferon epsilon (IFN-ε) is a type I IFN. Some biological properties has been identified in many species, such as antiproliferative, anti-tumor, and antiviral effects, of IFN-ε, which are much weaker than those of IFN-α, have also been revealed. It has been shown to play a role in mucosal immunity and bacterial infection and in the prevention of certain sexually transmitted diseases, such as human immunodeficiency virus (HIV). This paper reviews the known activity of IFN-ε, particularly in some viruses. In general, this review provides a better understanding of effective IFN-ε treatment in the future.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2022) conducted a review in Viral infections and mucosal immunity. Interferon epsilon (IFN-ε) was evaluated. Interferon epsilon is a unique type I interferon constitutively expressed in mucosal tissues that plays a crucial role in mucosal immunity and exhibits antiviral activity against pathogens like HIV.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: